A quarter of the patients with progression to COVID-19-associated ARDS presented with macrophage activation syndrome: high levels of CRP, ferritin, d-dimer, AST/ALT, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-6. Here, TNF is linked to macrophage activation syndrome.